Maarten van Dinther

3.0k total citations
44 papers, 2.3k citations indexed

About

Maarten van Dinther is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Maarten van Dinther has authored 44 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Maarten van Dinther's work include TGF-β signaling in diseases (29 papers), Congenital heart defects research (7 papers) and Heterotopic Ossification and Related Conditions (5 papers). Maarten van Dinther is often cited by papers focused on TGF-β signaling in diseases (29 papers), Congenital heart defects research (7 papers) and Heterotopic Ossification and Related Conditions (5 papers). Maarten van Dinther collaborates with scholars based in Netherlands, United Kingdom and China. Maarten van Dinther's co-authors include Peter ten Dijke, Clemens W.G.M. Löwik, Marion Scharpfenecker, Zhen Liu, Qinghai Zhao, R.L. van Bezooijen, Laurie Pukac, Jeroen T. Buijs, Martine Deckers and Gabri van der Pluijm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Maarten van Dinther

43 papers receiving 2.3k citations

Peers

Countries citing papers authored by Maarten van Dinther

Since Specialization

Citations

This map shows the geographic impact of Maarten van Dinther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten van Dinther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten van Dinther more than expected).

Fields of papers citing papers by Maarten van Dinther

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten van Dinther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten van Dinther. The network helps show where Maarten van Dinther may publish in the future.

Co-authorship network of co-authors of Maarten van Dinther

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten van Dinther. A scholar is included among the top collaborators of Maarten van Dinther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten van Dinther. Maarten van Dinther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dimerization‐dependent NOTCH receptor transactivation unveils a class of highly selective NOTCH signalling inhibitors 2025 ·FEBS Journal ·Xinxin Liu, (unknown), (unknown), Ling Wu, (unknown), Maarten van Dinther, Jin Liu, Manuel A.F.V. Gonçalves, Peter ten Dijke, D.A. Baker	0
2	The TGF-β mimic TGM4 achieves cell specificity through combinatorial surface co-receptor binding 2024 ·EMBO Reports ·Shashi Prakash Singh, Danielle J. Smyth, Kyle T. Cunningham, (unknown), Chang‐Hyeock Byeon, Cynthia S. Hinck, Madeleine P. J. White, (unknown), (unknown), (unknown), (unknown), Rosemary G. White, Sérgio Lilla, Sara Zanivan, Christina Schoenherr, Gareth J. Inman, Maarten van Dinther, Peter ten Dijke, Andrew P. Hinck, Rick M. Maizels	4
3	Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial–mesenchymal transition of breast cancer cells 2023 ·Cellular and Molecular Life Sciences ·Jing Zhang, Maarten van Dinther, Midory Thorikay, (unknown), Boudewijn P. T. Kruithof, Peter ten Dijke	14
4	Differential optineurin expression controls TGFβ signaling and is a key determinant for metastasis of triple negative breast cancer 2023 ·International Journal of Cancer ·(unknown), Maarten van Dinther, (unknown), (unknown), (unknown), Hailiang Mei, Maria Catalina Gomez‐Puerto, Wilma E. Mesker, Peter ten Dijke	3
5	Dynamic Visualization of TGF-β/SMAD3 Transcriptional Responses in Single Living Cells 2022 ·Cancers ·(unknown), Li You, Laura Bornes, Maarten van Dinther, Niek A. Peters, Hao Dang, (unknown), Marten Hornsveld, Onno Kranenburg, Jacco van Rheenen, Jos H. T. Rohling, Miao‐Ping Chien, Peter ten Dijke, Laila Ritsma	12
6	TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling 2022 ·Molecular Cancer Research ·Prasanna Vasudevan Iyengar, (unknown), Dilraj Lama, Tuan Zea Tan, (unknown), Feng Xie, Maarten van Dinther, Hailiang Mei, Chandra Verma, Long Zhang, Laila Ritsma, Peter ten Dijke	13
7	Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors 2021 ·Cancers ·(unknown), Jiang Ren, Midory Thorikay, Maarten van Dinther, Gonzalo Sánchez‐Duffhues, Josselin Caradec, (unknown), Jan Hoflack, Peter ten Dijke	5
8	TGF-β-Induced Endothelial to Mesenchymal Transition Is Determined by a Balance Between SNAIL and ID Factors 2021 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), Manuel A.F.V. Gonçalves, Maarten van Dinther, Midory Thorikay, Gonzalo Sánchez‐Duffhues, Peter ten Dijke	32
9	Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells 2020 ·Journal of Visualized Experiments ·Jing Zhang, Midory Thorikay, (unknown), Maarten van Dinther, Peter ten Dijke	1
10	Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells 2020 ·Journal of Visualized Experiments ·Jing Zhang, Midory Thorikay, (unknown), Maarten van Dinther, Peter ten Dijke	19
11	Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension 2019 ·The Journal of Pathology ·Maria Catalina Gomez‐Puerto, (unknown), (unknown), Robert Szulcek, (unknown), Maarten van Dinther, Kondababu Kurakula, (unknown), Marie‐José Goumans, Harm Jan Bogaard, Nicholas W. Morrell, Amer A. Rana, Peter ten Dijke	37
12	Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis 2019 ·Clinical Cancer Research ·Sijia Liu, Román González‐Prieto, Mengdi Zhang, Paul P. Geurink, Raymond Kooij, Prasanna Vasudevan Iyengar, Maarten van Dinther, Erik Bos, Xiaobing Zhang, Sylvia E. Le Dévédec, Bob van de Water, Roman I. Koning, Hong‐Jian Zhu, Wilma E. Mesker, Alfred C.O. Vertegaal, Huib Ovaa, Long Zhang, John W.M. Martens, Peter ten Dijke	106
13	USP 4 inhibits SMAD 4 monoubiquitination and promotes activin and BMP signaling 2017 ·The EMBO Journal ·Fangfang Zhou, Feng Xie, Ke Jin, Zhengkui Zhang, Marcello Clerici, Rui Gao, Maarten van Dinther, Titia K. Sixma, Huizhe Huang, Long Zhang, Peter ten Dijke	46
14	TMED10 Protein Interferes with Transforming Growth Factor (TGF)-β Signaling by Disrupting TGF-β Receptor Complex Formation 2017 ·Journal of Biological Chemistry ·Naoko Nakano, Yuki Tsuchiya, (unknown), (unknown), (unknown), Souichi Ikeno, Eri Otsuka, (unknown), (unknown), Nobuo Sakata, Fumiko Itoh, (unknown), Shun‐ichiro Iemura, Maarten van Dinther, Tohru Natsume, Peter ten Dijke, Susumu Itoh	18
15	Transforming Growth Factor beta Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2 2015 ·PLoS ONE ·Noel F.C.C. de Miranda, Maarten van Dinther, Brendy E.W.M. van den Akker, Tom van Wezel, Peter ten Dijke, Hans Morreau	1
16	TGFβ Activates Mitogen- and Stress-activated Protein Kinase-1 (MSK1) to Attenuate Cell Death 2010 ·Journal of Biological Chemistry ·Lars P. van der Heide, Maarten van Dinther, Aristidis Moustakas, Peter ten Dijke	25
17	Smad3 Is a Key Nonredundant Mediator of Transforming Growth Factor β Signaling in Nme Mouse Mammary Epithelial Cells 2009 ·Molecular Cancer Research ·Joanna Dzwonek, Olena Preobrazhenska, (unknown), Andrea Conidi, Ann Schellens, Maarten van Dinther, Andrew Stubbs, Anke Klippel, Danny Huylebroeck, Peter ten Dijke, Kristin Verschueren	24
18	Autocrine Bone Morphogenetic Protein-9 Signals through Activin Receptor-like Kinase-2/Smad1/Smad4 to Promote Ovarian Cancer Cell Proliferation 2009 ·Cancer Research ·Blanca Herrera, Maarten van Dinther, Peter ten Dijke, Gareth J. Inman	103
19	BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis 2007 ·Journal of Cell Science ·Marion Scharpfenecker, Maarten van Dinther, Zhen Liu, R.L. van Bezooijen, Qinghai Zhao, Laurie Pukac, Clemens W.G.M. Löwik, Peter ten Dijke	415
20	The Tumor Suppressor Smad4 Is Required for Transforming Growth Factor β–Induced Epithelial to Mesenchymal Transition and Bone Metastasis of Breast Cancer Cells 2006 ·Cancer Research ·Martine Deckers, Maarten van Dinther, Jeroen T. Buijs, Ivo Que, Clemens W.G.M. Löwik, Gabri van der Pluijm, Peter ten Dijke	310

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact